Full Text View
Tabular View
Study Results
Related Studies
Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular Disease (MK-0974-034)
This study has been completed.
Study NCT00662818   Information provided by Merck Sharp & Dohme Corp.

First Received on April 17, 2008.   Last Updated on September 15, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial